Table 3.
Trends in 30 day mortality following neurosurgical treatment of metastatic breast cancer.
| 30 day mortality | Surgery prior to 1996 | Surgery after 1996 | P value | |
|---|---|---|---|---|
| All surgeries | 9.0% (58/585) | 10.1% (30/268) | 8.1% (28/317) | .4 |
| Cranial | 9.1% (24/240) | 11.2% (12/95) | 7.6% (12/145) | .3 |
| Laminectomy (no fusion) | 9.8% (17/157) | <10%* | <10%* | 1.0 |
| Fusion | 8.3% (17/188) | <9%* | <8%* | .8 |
Actual value not reportable due to SEER-Medicare patient confidentiality restrictions on reporting results with N<11